When you’ve stared cancer in the face like I have, you don’t waste time chasing half-truths or sugar-coated promises. You start asking the hard questions—like why are we still blasting people with poison when gentler, smarter options are emerging every day? One of the most exciting, drug-free breakthroughs I’ve seen lately doesn’t come from a pill or a needle—but from sound.

That’s right—scientists are using targeted sound waves to break up tumors, open the blood-brain barrier, and jumpstart the body’s own healing response. No chemo. No radiation. Just pure innovation. And it could change everything for people who feel out of options.

You won’t hear about this on the nightly news—not yet, anyway. But doctors and researchers at some of the world’s top institutions are quietly studying how low-intensity focused ultrasound (LIFU) and histotripsy—a kind of tumor “pulverizing” sound therapy—can treat cancer without cutting, burning, or poisoning the body.

One study out of the University of Michigan used histotripsy to destroy liver tumors in patients with promising results. And in another fascinating trial, doctors used sound waves to temporarily open the blood-brain barrier—a protective shield that usually blocks medication from reaching the brain. Why does that matter? Because for patients with tough cancers like glioblastoma, this could finally allow treatments to get where they’re needed most. That kind of bold, out-of-the-box thinking reminds me of what I had to embrace over 40 years ago when I chose to walk a different path to healing—and it’s the kind of thinking that’s long overdue in medicine today.

Two New Promising Therapies

>> Histotripsy. The name says a lot — “histo” means tissue, and “tripsy” means to crush or break. So histotripsy literally means “tissue crushing,” and that’s exactly what this therapy does—but in a surprisingly gentle way. There’s no cutting, no burning, and no drugs involved. Instead, it uses focused sound waves to create tiny bubbles inside the tumor. When those bubbles rapidly expand and collapse, they break the tumor apart from the inside. It’s completely non-invasive, doesn’t generate heat, and leaves nearby healthy tissue untouched. Even more promising? Early studies suggest it may also help stimulate the immune system to recognize and attack cancer cells. For anyone seeking smarter, safer approaches to healing—this is one to watch.

Early clinical trials show a histotripsy success rate of 95.5%. In 2024, Swedish First Hill became the first hospital on the West Coast to offer histotripsy to people with liver cancer. You can visit this link and complete an online form to see if you’re a candidate: https://www.swedish.org/locations/first-hill-campus/cancer-institute-first-hill-treatment-center/histotripsy

>> LIFU, short for Low-Intensity Focused Ultrasound, is a promising new technique that allows doctors to briefly open the brain’s protective shield—known as the blood-brain barrier. While this barrier plays an important role in keeping the brain safe, it can also block access to areas that need support. With LIFU, doctors can gently “unlock” it for a short time, making it possible to reach parts of the brain that were once off-limits.

It’s completely non-invasive and currently being studied at leading research centers like Sunnybrook in Toronto and the University of Maryland. While it’s still in the early stages, the potential for LIFU to safely reach and support healing in the brain is giving new hope to patients and families looking for better options.

The Bottom Line

Here at the Templeton Wellness Foundation, we believe real healing happens when we work with the body’s natural design, not against it. Therapies like histotripsy and LIFU may still be emerging, but the science behind them is solid and growing fast. For those seeking safer, more effective options, these sound-based approaches offer a kind of hope we don’t often see in modern cancer care. We’re keeping a close eye on this promising new frontier—and we’ll keep sharing what we find.

Sources:

Histotripsy Liver Tumor Trial – University of Michigan: https://www.michiganmedicine.org/health-lab/histotripsy-liver-tumor-trial-successful-early-clinical-adoption-recommended

Focused Ultrasound for Glioblastoma – FUS Foundation: https://www.fusfoundation.org/diseases-and-conditions/glioblastoma/

ASCO: LIFU Clinical Trial Abstract: https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.TPS2098

“Providence Swedish Makes History with Histotripsy.” https://www.swedish.org/news/uf/686449730

Ahluwalia, Manmeet S., Ahmad Ozair, Arjun Sahgal, Terry C. Burns, John F. de Groot, Alon Mogilner, Achal Achrol, et al. “A Prospective, Multicenter Trial of Low-Intensity Focused Ultrasound (LIFU) for Blood-Brain Barrier Disruption for Liquid Biopsy in Glioblastoma (LIBERATE).” Journal of Clinical Oncology 42, no. 16_suppl (June 2024): TPS2098. https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.TPS2098.

Ahluwalia MS, McDermott M, Ozair A, Khosla AA, Sahgal A, Mishra M, Achrol A, Woodworth G, Lipsman N. P07.13.B A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS). Neuro Oncol. 2023 Sep 8;25(Suppl 2):ii54. doi: 10.1093/neuonc/noad137.173. PMCID: PMC10489181.

Eat Healthy, Wherever You Are!

Visit The Templeton List